IMPACT OF PRE-TRANSPLANT RITUXIMAB ON SURVIVAL AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR DIFFUSE LARGE B-CELL LYMPHOMA

Incorporation of the anti-CD20 monoclonal antibody rituximab into front-line regimens for diffuse large B-cell lymphoma (DLBCL) has resulted in improved survival. Despite this progress, many patients develop refractory or recurrent DLBCL and then receive autologous hematopoietic stem cell transplant...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fenske, Timothy S., Hari, Parameswaran N., Carreras, Jeanette, Zhang, Mei-Jie, Kamble, Rammurti T., Bolwell, Brian J., Cairo, Mitchell S., Champlin, Richard E., Chen, Yi-Bin, Freytes, César O., Gale, Robert Peter, Hale, Gregory A., Ilhan, Osman, Khoury, H. Jean, Lister, John, Maharaj, Dipnarine, Marks, David I., Munker, Reinhold, Pecora, Andrew L., Rowlings, Philip A., Shea, Thomas C., Stiff, Patrick, Wiernik, Peter H., Winter, Jane N., Rizzo, J. Douglas, van Besien, Koen, Lazarus, Hillard M., Vose, Julie M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913553/
https://ncbi.nlm.nih.gov/pubmed/19822306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.07.017
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky